Chronic cough, persisting for more than eight weeks, poses a significant diagnostic and therapeutic challenge in clinical practice. This article aims to provide a comprehensive approach to managing this common yet complex condition.
Chronic cough is often a symptom of underlying conditions such as gastroesophageal reflux disease (GERD), asthma, and upper airway cough syndrome (UACS). It could also be idiopathic in nature. The pathophysiology involves a hypersensitive cough reflex triggered by inflammation and neuronal changes.
Initial evaluation should aim to identify common causes using a thorough history, physical examination, and basic investigations such as chest X-ray and spirometry. If the cause remains elusive, further investigations including high-resolution computed tomography, bronchoscopy, and esophageal pH monitoring may be warranted.
Treatment should be tailored to the underlying cause. For GERD-induced cough, proton pump inhibitors are recommended. Inhaled corticosteroids are beneficial in asthma-related cough, while antihistamines and decongestants may help in UACS. If the cough is idiopathic, neuromodulators such as gabapentin can be considered.
In refractory cases, a multi-disciplinary approach involving pulmonologists, gastroenterologists, and otolaryngologists may be necessary. Cognitive-behavioral therapy has also shown promise in managing chronic refractory cough.
Chronic cough management requires a systematic and comprehensive approach. Identifying the underlying cause is crucial to guide treatment. In refractory cases, a multi-disciplinary approach and novel therapies may be required. Continued research is needed to better understand the pathophysiology and to develop more effective treatment strategies.
1.
Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions
2.
Sevabertinib Approved for First-Line Mutated NSCLC
3.
After three years, responses to mounetuzumab in follicular lymphoma are still stable.
4.
FDA Bans Red Dye No. 3 From Foods, Ingested Drugs
5.
AI can identify women at risk of breast cancer years in advance: Study
1.
Revolutionizing Cancer Treatment: Advances in Immunotherapy and Cell Therapy
2.
Pediatric Tumor Microenvironment Evolution: Mechanisms, Clinical Impact, and Therapeutic Implications
3.
Hematopoietic Stem Cell Activity Biomarkers in Aging
4.
Bone-Marrow Immune Cell Competition: Mechanisms, Clinical Implications, and Emerging Therapeutic Perspectives
5.
The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
Emerging Concepts in Hematology
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation